Annabel Samimy
Stock Analyst at Stifel
(4.29)
# 450
Out of 4,732 analysts
61
Total ratings
43.4%
Success rate
26.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $27.06 | +84.77% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $6.86 | +162.39% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $2.16 | +687.04% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $9.89 | +304.45% | 1 | Oct 8, 2024 | |
| RVNC Revance Therapeutics | Maintains: Buy | $24 → $20 | $3.68 | +443.48% | 3 | Aug 9, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $7.16 | +151.40% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $6.96 | +244.83% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $7.37 | +442.74% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $32.65 | +145.02% | 6 | Mar 15, 2024 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $225 → $230 | $121.18 | +89.80% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $10.51 | +137.87% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.74 | +53.91% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $29.94 | +117.14% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $336 | $4.65 | +7,125.81% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $0.57 | +1,820.39% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $9.24 | +387.01% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.93 | +760.31% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $1.31 | +1,732.06% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $12.74 | +56.99% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.06 | +70,654.72% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $37.74 | -36.41% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.85 | +2,370.88% | 6 | Sep 18, 2019 |
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $27.06
Upside: +84.77%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $6.86
Upside: +162.39%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $2.16
Upside: +687.04%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $9.89
Upside: +304.45%
Revance Therapeutics
Aug 9, 2024
Maintains: Buy
Price Target: $24 → $20
Current: $3.68
Upside: +443.48%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.16
Upside: +151.40%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $6.96
Upside: +244.83%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $7.37
Upside: +442.74%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $32.65
Upside: +145.02%
Jazz Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $121.18
Upside: +89.80%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $10.51
Upside: +137.87%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $22.74
Upside: +53.91%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $29.94
Upside: +117.14%
Jun 27, 2023
Reiterates: Buy
Price Target: $336
Current: $4.65
Upside: +7,125.81%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $0.57
Upside: +1,820.39%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $9.24
Upside: +387.01%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.93
Upside: +760.31%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $1.31
Upside: +1,732.06%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $12.74
Upside: +56.99%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.06
Upside: +70,654.72%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $37.74
Upside: -36.41%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.85
Upside: +2,370.88%